相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteasomal Degradation of the Papillomavirus E2 Protein Is Inhibited by Overexpression of Bromodomain-Containing Protein 4
David Gagnon et al.
JOURNAL OF VIROLOGY (2009)
Tissue-Spanning Redox Gradient-Dependent Assembly of Native Human Papillomavirus Type 16 Virions
Michael J. Conway et al.
JOURNAL OF VIROLOGY (2009)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
J. Paovonen et al.
LANCET (2009)
Effects of environmental tobacco smoke in vivo on rhesus monkey semen quality, sperm function, and sperm metabolism
Pei-hsuan Hung et al.
REPRODUCTIVE TOXICOLOGY (2009)
Interaction of human papillomaviruses with the host immune system: A well evolved relationship
Ian H. Frazer
VIROLOGY (2009)
The E8∧E2 Gene Product of Human Papillomavirus Type 16 Represses Early Transcription and Replication but Is Dispensable for Viral Plasmid Persistence in Keratinocytes
Michael J. Lace et al.
JOURNAL OF VIROLOGY (2008)
Human Papillomavirus E7 requires the protease calpain to degrade the retinoblastoma protein
Grant A. Darnell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins
Mako Narisawa-Saito et al.
CANCER SCIENCE (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma
Saeed Khan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs
Aagje G. Bais et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
L. L. Villa et al.
BRITISH JOURNAL OF CANCER (2006)
Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands
Anita B. Bos et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Sexual and reproductive health 2 - Sexual behaviour in context: a global perspective
Kaye Wellings et al.
LANCET (2006)
Interferon-β treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants
M. Trent Herdman et al.
CARCINOGENESIS (2006)
Prevalence of HPV infection among men: A systematic review of the literature
Eileen F. Dunne et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms
Andreas Mueller-Schiffmann et al.
JOURNAL OF VIROLOGY (2006)
Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial
DM Harper et al.
LANCET (2006)
Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6
A Incassati et al.
ONCOGENE (2006)
Estrogen receptors and human disease
BJ Deroo et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation
BY Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR
Leen-Jan van Doorn et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
The carcinogenicity of human papillornavirus types reflects viral evolution
M Schiffman et al.
VIROLOGY (2005)
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
R Herrero et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
The cervical cancer epidemic that screening has prevented in the UK
J Peto et al.
LANCET (2004)
Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial
DM Harper et al.
LANCET (2004)
Natural history of human papillomavirus type 16 virus-like particle antibodies in young women
GYF Ho et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2004)
Relationship between steroid hormone contraceptives and HPV, cervical intraepithelial neoplasia and cervical carcinoma
EM de Villiers
INTERNATIONAL JOURNAL OF CANCER (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prevalence of human papillomavirus infection in women in Busan, South Korea
HR Shin et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Seroprevalence of human papillomavirus type 16 infection in the United States
KM Stone et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The causal relation between human papillomavirus and cervical cancer
FX Bosch et al.
JOURNAL OF CLINICAL PATHOLOGY (2002)
分享论文
